See more : eFUEL EFN CORPORATION (EFLN) Income Statement Analysis – Financial Results
Complete financial analysis of Clever Leaves Holdings Inc. (CLVR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clever Leaves Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Savannah Energy PLC (SAVE.L) Income Statement Analysis – Financial Results
- Iron Force Industrial Co., Ltd. (2228.TW) Income Statement Analysis – Financial Results
- LPKF Laser & Electronics AG (LPK.DE) Income Statement Analysis – Financial Results
- baudroie,inc. (4413.T) Income Statement Analysis – Financial Results
- Devro plc (DEITF) Income Statement Analysis – Financial Results
Clever Leaves Holdings Inc. (CLVR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cleverleaves.com
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.42M | 17.80M | 15.37M | 12.12M | 7.83M | 0.00 |
| Cost of Revenue | 10.86M | 13.47M | 8.57M | 4.70M | 4.73M | 99.00K |
| Gross Profit | 6.56M | 4.33M | 6.81M | 7.41M | 3.10M | -99.00K |
| Gross Profit Ratio | 37.64% | 24.33% | 44.29% | 61.18% | 39.60% | 0.00% |
| Research & Development | 1.14M | 1.72M | 1.55M | 1.01M | 0.00 | 0.00 |
| General & Administrative | 17.99M | 27.82M | 38.40M | 29.83M | 34.98M | 4.75M |
| Selling & Marketing | 2.04M | 1.90M | 3.80M | 2.58M | 3.18M | 417.00K |
| SG&A | 20.03M | 29.71M | 42.19M | 32.41M | 38.16M | 5.31M |
| Other Expenses | 0.00 | 2.06M | 1.77M | 1.85M | 1.48M | 0.00 |
| Operating Expenses | 21.17M | 33.49M | 45.51M | 34.26M | 39.64M | 5.31M |
| Cost & Expenses | 33.01M | 46.96M | 54.07M | 38.96M | 44.37M | 5.41M |
| Interest Income | 0.00 | 2.70M | 6.82M | 4.46M | 2.68M | 390.00K |
| Interest Expense | 46.00K | 2.70M | 6.82M | 4.46M | 2.68M | 0.00 |
| Depreciation & Amortization | 2.85M | 3.67M | 3.51M | 3.59M | 1.48M | 99.00K |
| EBITDA | -16.84M | -35.80M | -35.19M | -23.26M | -41.72M | -5.31M |
| EBITDA Ratio | -96.66% | -144.33% | -225.63% | -203.91% | -454.35% | 0.00% |
| Operating Income | -15.59M | -29.16M | -38.70M | -26.85M | -36.54M | -5.41M |
| Operating Income Ratio | -89.53% | -163.82% | -251.72% | -221.56% | -466.43% | 0.00% |
| Total Other Income/Expenses | -4.14M | -15.00M | -5.98M | 951.00K | -9.34M | 13.15M |
| Income Before Tax | -19.73M | -72.46M | -44.68M | -36.68M | -45.88M | 7.74M |
| Income Before Tax Ratio | -113.27% | -407.05% | -290.63% | -302.67% | -585.70% | 0.00% |
| Income Tax Expense | 68.00K | -6.35M | 950.00K | 4.74M | 2.25M | -126.00K |
| Net Income | -17.90M | -66.10M | -45.63M | -41.41M | -48.13M | 7.36M |
| Net Income Ratio | -102.77% | -371.35% | -296.81% | -341.78% | -614.37% | 0.00% |
| EPS | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| EPS Diluted | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| Weighted Avg Shares Out | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
Clever Leaves Reports Third Quarter 2023 Results
- Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue -
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET
TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Thursday, November 9, 2023 at 5:00 p.m. Eastern time...
Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement
TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on September 11,...
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company
The CO2 Neutrality Certification Reflects Clever Leaves' Commitment to Environmental Sustainability and long-term vision for the cannabis industry.
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
TOCANCIPÁ, Colombia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Board of Directors has approved a 1-for-30 reverse split of its common...
Clever Leaves Holdings, Inc. (CLVR) Q2 2023 Earnings Call Transcript
Clever Leaves Holdings, Inc. (NASDAQ:CLVR ) Q2 2023 Earnings Conference Call August 14, 2023 5:00 PM ET Company Participants Andres Fajardo - CEO Hank Hague - CFO Conference Call Participants Diana Tokar - Canaccord Genuity Operator Good afternoon, everyone, and...
Clever Leaves Reports Second Quarter 2023 Results
- Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue - - Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million - - July 2023 Sale of Portuguese Processing Assets Added $2.7 Million in...
3 Top Marijuana Stocks To Watch Before The Weekend
Many cannabis companies are starting to release earnings this month. With strong earnings, some marijuana stocks could soon see a rise in momentum. At times when one or more companies report strong financials it can lead to trading off of...
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET
TOCANCIPÁ, Colombia, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Monday, August 14, 2023 at 5:00 p.m. Eastern time...
Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
TOCANCIPÁ, Colombia and SYDNEY, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Colombian flower is now available to patients in Australia...
Source: https://incomestatements.info
Category: Stock Reports